Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas Werner Weiss"'
Autor:
Susanne Claudia Gruber, Matthias Karl Freynhofer, Martin Willheim, Thomas Werner Weiss, Florian Egger, Wolfgang Hübl, Kurt Huber
Publikováno v:
Platelets, Vol 30, Iss 4, Pp 506-512 (2019)
Long-term evidence shows an increased risk of cardiovascular events in the morning hours and recent studies in aspirin-treated patients have shown increased platelet reactivity at the end of the dosing interval. Similar pharmacodynamic analyses of ad
Externí odkaz:
https://doaj.org/article/ac5c2a6113e840929849ea86ac81f3a3
Autor:
David Zweiker, Thomas Lambert, Clemens Steinwender, Thomas Weber, Markus Suppan, Helmut Brussee, Christian Koppelstätter, Julia Kerschbaum, Bruno Watschinger, Katharina Hohenstein-Scheibenecker, Roman Reindl-Schwaighofer, Thomas Sturmberger, Claudia Kindslehner, Thomas Werner Weiss, Miklos Rohla, Peter Gruener, Petra Maister, Johann Auer, Cornelia Dechant, Josef Sykora, Christoph Krismer, Stefan Glaser, Robert Zweiker
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161250 (2016)
Renal denervation (RDN) is a new procedure for treatment-resistant hypertensive patients. In order to monitor all procedures undergone in Austria, the Austrian Society of Hypertension established the investigator-initiated Austrian Transcatheter Rena
Externí odkaz:
https://doaj.org/article/54101aee3b92488c95560002bc6522a1
Autor:
Maximillian Will, Thomas Werner Weiss
Publikováno v:
Internal and emergency medicine. 17(3)
Autor:
Thomas Werner, Weiss, Rainer, Simak, Christoph, Kaun, Gersina, Rega, Heinz, Pflüger, Gerald, Maurer, Kurt, Huber, Johann, Wojta
Publikováno v:
Anticancer research. 31(10)
Oncostatin M (OSM) and interleukin-6 (IL-6) are growth factors for prostate cancer (PC). Vascular endothelial growth factor (VEGF) and urokinase-type plasminogen-activator (u-PA) have been implicated in tumour progression. A possible interaction betw